[Acute leukemia after aplastic anemia in childhood]
Related Experiment Video
Updated: Oct 14, 2026
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
1Abteilung für Hämatologie und Onkologie, Technischen Universität Dresden.
Insights
Childhood acute lymphoblastic leukemia (ALL) after aplastic anemia presents with diverse immunophenotypes. Early antileukemic treatment post-recovery is crucial due to varied responses and potential mortality.
Area of Science:
- Pediatric Hematology Oncology
- Leukemia Immunophenotyping
- Aplastic Anemia Complications
Background:
- Reports on acute lymphoblastic leukemia (ALL) following childhood aplastic anemia are scarce.
- The immunophenotypic spectrum of secondary ALL remains poorly defined.
- Understanding these secondary leukemias is critical for appropriate management.
Observation:
- Two pediatric cases of ALL post-aplastic anemia were analyzed.
- Case 1 presented with common c-ALL.
- Case 2 exhibited a mixed phenotype with myeloid and T-cell markers, proving difficult to classify.
Findings:
- The immunophenotype of secondary ALL can vary significantly.
- The mixed-phenotype leukemia showed poor therapeutic response.
- One patient experienced short recovery phases before succumbing to the disease.
Implications:
- Post-aplastic anemia ALL requires careful immunophenotypic assessment.
- Prompt initiation of antileukemic therapy after aplastic anemia recovery is recommended.
- Prednisolone-induced recovery from aplastic anemia may precede diverse ALL presentations.
Abstract:
Only few reports about ALL after aplastic anaemias in childhood exist. It remains still unclear which immunophenotypes of the leukaemias must be expected thereafter. Here it is reported about two children with quite different immunophenotypes of the leukaemic cells. In the first one the most common type was found, the constellation of a c-ALL, whereas in the other the precise classification was impossible at all. Myeloic and T-cell markers were present at the same time. This form of leukaemia was not influenced therapeutically in a sufficient manner. The patient died after recovery phases of only short duration. After aplastic anaemias with fast recovery by prednisolone ALL of different constellation has to be expected. Therefore the antileukaemic treatment immediately after recovery of the aplastic anaemia should be taken into consideration.
More Related Videos
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
08:31Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Related Concept Videos
01:21Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:27Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
01:22Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:25Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...